MetaCap

Kairos Pharma (KAPA) vs Lakewood-Amedex Biotherapeutics (LABT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Lakewood-Amedex Biotherapeutics is the larger company by market cap ($2.2 million vs $2.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KAPA-49.90%LABT-71.18%
+15%-34%-83%
Oct 7, 20261 yearNov 20, 2026
KAPA-46.21%LABT-68.69%
+4%-37%-78%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KAPA versus LABT key metrics
MetricKAPALABT
Share price$0.4359$0.2449
Market cap$2.04M$2.19M
1-day change-4.62%+15.03%
EPS (TTM)$-2.09$-5.57
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-5.45M—
52-week high$7.28$98.20
52-week low$0.381$0.17
Distance from 52-week high-94.01%-99.75%
Analyst consensusnonestrong_buy
Avg. price target upside+11141.11%+4799.96%
Average volume364.25K16.14M
Shares outstanding4.69M8.95M
Employees15
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Kairos Pharma

KAPA stock →

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

About Lakewood-Amedex Biotherapeutics

LABT stock →

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

KAPA vs LABT FAQ

Which is bigger, Kairos Pharma or Lakewood-Amedex Biotherapeutics?

Lakewood-Amedex Biotherapeutics (LABT) is larger, with a market capitalization of $2.19M compared with $2.04M for Kairos Pharma (KAPA).

Are Kairos Pharma and Lakewood-Amedex Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons